Hopewell Therapeutics has filed a notice of an exempt offering of securities to raise $10,000,001.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Hopewell Therapeutics is raising $10,000,001.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Louis Brenner played a…